Open AccessHigh-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study
Author(s) -
Raúl JuntasMorales,
Nicolas Pageot,
Abdelkarim Bendarraz,
Sébastien Alphandery,
Frédéric Sedel,
Stéphanie Seigle,
William Camu
Publication year - 2020
Publication title -
eclinicalmedicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.915
H-Index - 20
ISSN - 2589-5370
DOI - 10.1016/j.eclinm.2019.100254
Subject(s) - medicine , amyotrophic lateral sclerosis , placebo , adverse effect , population , clinical endpoint , clinical trial , multiple sclerosis , physical therapy , disease , pathology , psychiatry , environmental health , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom